Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort (Q37006537)

17 August 2017

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort (English)

1 reference

17 August 2017

1 reference

1 reference

1 reference

Georgios Lypas

13

0 references

Mark Robson

object named as

Mark Robson

4

0 references

Jeffrey N Weitzel

5

object named as

Jeffrey N Weitzel

1 reference

17 August 2017

8

James M Ford

1 reference

17 August 2017

14

Judy E Garber

1 reference

17 August 2017

Serena Masciari

1

1 reference

17 August 2017

Deborah A Dillon

2

1 reference

17 August 2017

Michelle Rath

3

1 reference

17 August 2017

Judith Balmana

6

1 reference

17 August 2017

Stephen B Gruber

7

1 reference

17 August 2017

David Euhus

9

1 reference

17 August 2017

Alexandra Lebensohn

10

1 reference

17 August 2017

Melinda Telli

11

1 reference

17 August 2017

Stephen M Pochebit

12

1 reference

17 August 2017

language of work or name

English

0 references

publication date

4 March 2012

1 reference

Breast Cancer Research and Treatment

17 August 2017

1 reference

17 August 2017

133

1 reference

17 August 2017

1125-1130

1 reference

17 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-012-1993-9

17 August 2017

0 references

cites work

Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Adjuvant trastuzumab in HER2-positive breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Early onset HER2-positive breast cancer is associated with germline TP53 mutations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

The distinctive nature of HER2-positive breast cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Repeated observation of breast tumor subtypes in independent gene expression data sets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Li-Fraumeni syndrome--a molecular and clinical review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Breast carcinomas occurring in young women (< 35 years) are different

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

A cancer family syndrome in twenty-four kindreds

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

Women age < or = 35 years with primary breast carcinoma: disease features at presentation

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-012-1993-9

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-012-1993-9

Screening for germ line TP53 mutations in breast cancer patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709568

p53 abnormalities and genomic instability in primary human breast carcinomas

20 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22392042

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

2009 Version of the Chompret Criteria for Li Fraumeni Syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22392042

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10549-012-1993-9

1 reference

17 August 2017

1 reference

17 August 2017

1 reference